Lv6
2320 积分 2023-08-21 加入
Association of Lipoprotein(a) and Interleukin-6 With Cardiovascular Risk: MESA and UK Biobank
1天前
已完结
Pharmacokinetics and pharmacodynamics of inclisiran, a small interfering RNA therapy, in patients with hepatic impairment
8天前
已完结
Predicting Clinical Pharmacokinetics/Pharmacodynamics and Impact of Organ Impairment on siRNA-Based Therapeutics Using a Mechanistic Physiologically-Based Pharmacokinetic-Pharmacodynamic Model
8天前
已完结
Therapeutic PCSK9 targeting: Inside versus outside the hepatocyte?
18天前
已完结
Safety and Lipid-Lowering Efficacy of Inclisiran Monotherapy in Patients Without ASCVD: The VICTORION-Mono Randomized Clinical Trial
23天前
已完结
Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study
25天前
已完结
Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
25天前
已完结
Intravascular Imaging- vs Angiography-Guided Complex PCI: 5-Year Outcomes From a Randomized Trial
1个月前
已完结
皖公网安备34019202002308
